This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bilodeau, P. S.
Right arrow Articles by Stoltzfus, C. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bilodeau, P. S.
Right arrow Articles by Stoltzfus, C. M.

 Previous Article  |  Next Article 

Journal of Virology, September 2001, p. 8487-8497, Vol. 75, No. 18
0022-538X/01/$04.00+0   DOI: 10.1128/JVI.75.18.8487-8497.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.

RNA Splicing at Human Immunodeficiency Virus Type 1 3' Splice Site A2 Is Regulated by Binding of hnRNP A/B Proteins to an Exonic Splicing Silencer Element

Patricia S. Bilodeau,1 Jeffrey K. Domsic,2 Akila Mayeda,3 Adrian R. Krainer,4 and C. Martin Stoltzfus1,2,*

Department of Microbiology1 and Program in Molecular Biology,2 University of Iowa, Iowa City, Iowa 52242; Department of Biochemistry and Molecular Biology, University of Miami School of Medicine, Miami, Florida 331363; and Cold Spring Harbor Laboratory, Cold Spring Harbor, New York 11724-22084

Received 22 February 2001/Accepted 8 June 2001

The synthesis of human immunodeficiency virus type 1 (HIV-1) mRNAs is a complex process by which more than 30 different mRNA species are produced by alternative splicing of a single primary RNA transcript. HIV-1 splice sites are used with significantly different efficiencies, resulting in different levels of mRNA species in infected cells. Splicing of Tat mRNA, which is present at relatively low levels in infected cells, is repressed by the presence of exonic splicing silencers (ESS) within the two tat coding exons (ESS2 and ESS3). These ESS elements contain the consensus sequence PyUAG. Here we show that the efficiency of splicing at 3' splice site A2, which is used to generate Vpr mRNA, is also regulated by the presence of an ESS (ESSV), which has sequence homology to ESS2 and ESS3. Mutagenesis of the three PyUAG motifs within ESSV increases splicing at splice site A2, resulting in increased Vpr mRNA levels and reduced skipping of the noncoding exon flanked by A2 and D3. The increase in Vpr mRNA levels and the reduced skipping also occur when splice site D3 is mutated toward the consensus sequence. By in vitro splicing assays, we show that ESSV represses splicing when placed downstream of a heterologous splice site. A1, A1B, A2, and B1 hnRNPs preferentially bind to ESSV RNA compared to ESSV mutant RNA. Each of these proteins, when added back to HeLa cell nuclear extracts depleted of ESSV-binding factors, is able to restore splicing repression. The results suggest that coordinate repression of HIV-1 RNA splicing is mediated by members of the hnRNP A/B protein family.


* Corresponding author. Mailing address: Department of Microbiology and Program in Molecular Biology, University of Iowa, Iowa City, IA 52242. Phone: (319) 335-7793. Fax: (319) 335-9006. E-mail: marty-stoltzfus{at}uiowa.edu.


Journal of Virology, September 2001, p. 8487-8497, Vol. 75, No. 18
0022-538X/01/$04.00+0   DOI: 10.1128/JVI.75.18.8487-8497.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Monette, A., Ajamian, L., Lopez-Lastra, M., Mouland, A. J. (2009). Human Immunodeficiency Virus Type 1 (HIV-1) Induces the Cytoplasmic Retention of Heterogeneous Nuclear Ribonucleoprotein A1 by Disrupting Nuclear Import: IMPLICATIONS FOR HIV-1 GENE EXPRESSION. J. Biol. Chem. 284: 31350-31362 [Abstract] [Full Text]  
  • Venables, J. P., Koh, C.-S., Froehlich, U., Lapointe, E., Couture, S., Inkel, L., Bramard, A., Paquet, E. R., Watier, V., Durand, M., Lucier, J.-F., Gervais-Bird, J., Tremblay, K., Prinos, P., Klinck, R., Elela, S. A., Chabot, B. (2008). Multiple and Specific mRNA Processing Targets for the Major Human hnRNP Proteins. Mol. Cell. Biol. 28: 6033-6043 [Abstract] [Full Text]  
  • Exline, C. M., Feng, Z., Stoltzfus, C. M. (2008). Negative and Positive mRNA Splicing Elements Act Competitively To Regulate Human Immunodeficiency Virus Type 1 Vif Gene Expression. J. Virol. 82: 3921-3931 [Abstract] [Full Text]  
  • Sajic, R., Lee, K., Asai, K., Sakac, D., Branch, D. R., Upton, C., Cochrane, A. (2007). Use of modified U1 snRNAs to inhibit HIV-1 replication. Nucleic Acids Res 35: 247-255 [Abstract] [Full Text]  
  • Kraunus, J., Zychlinski, D., Heise, T., Galla, M., Bohne, J., Baum, C. (2006). Murine Leukemia Virus Regulates Alternative Splicing through Sequences Upstream of the 5{middle dot} Splice Site. J. Biol. Chem. 281: 37381-37390 [Abstract] [Full Text]  
  • Hallay, H., Locker, N., Ayadi, L., Ropers, D., Guittet, E., Branlant, C. (2006). Biochemical and NMR Study on the Competition between Proteins SC35, SRp40, and Heterogeneous Nuclear Ribonucleoprotein A1 at the HIV-1 Tat Exon 2 Splicing Site. J. Biol. Chem. 281: 37159-37174 [Abstract] [Full Text]  
  • Szeszel-Fedorowicz, W., Talukdar, I., Griffith, B. N., Walsh, C. M., Salati, L. M. (2006). An Exonic Splicing Silencer Is Involved in the Regulated Splicing of Glucose 6-Phosphate Dehydrogenase mRNA. J. Biol. Chem. 281: 34146-34158 [Abstract] [Full Text]  
  • Lutzelberger, M., Reinert, L. S., Das, A. T., Berkhout, B., Kjems, J. (2006). A Novel Splice Donor Site in the gag-pol Gene Is Required for HIV-1 RNA Stability. J. Biol. Chem. 281: 18644-18651 [Abstract] [Full Text]  
  • Lei, H., Vorechovsky, I. (2005). Identification of Splicing Silencers and Enhancers in Sense Alus: a Role for Pseudoacceptors in Splice Site Repression. Mol. Cell. Biol. 25: 6912-6920 [Abstract] [Full Text]  
  • Madsen, J. M., Stoltzfus, C. M. (2005). An Exonic Splicing Silencer Downstream of the 3' Splice Site A2 Is Required for Efficient Human Immunodeficiency Virus Type 1 Replication. J. Virol. 79: 10478-10486 [Abstract] [Full Text]  
  • Zhao, X., Rush, M., Schwartz, S. (2004). Identification of an hnRNP A1-Dependent Splicing Silencer in the Human Papillomavirus Type 16 L1 Coding Region That Prevents Premature Expression of the Late L1 Gene. J. Virol. 78: 10888-10905 [Abstract] [Full Text]  
  • Beriault, V., Clement, J.-F., Levesque, K., LeBel, C., Yong, X., Chabot, B., Cohen, E. A., Cochrane, A. W., Rigby, W. F. C., Mouland, A. J. (2004). A Late Role for the Association of hnRNP A2 with the HIV-1 hnRNP A2 Response Elements in Genomic RNA, Gag, and Vpr Localization. J. Biol. Chem. 279: 44141-44153 [Abstract] [Full Text]  
  • Expert-Bezancon, A., Sureau, A., Durosay, P., Salesse, R., Groeneveld, H., Lecaer, J. P., Marie, J. (2004). hnRNP A1 and the SR Proteins ASF/SF2 and SC35 Have Antagonistic Functions in Splicing of {beta}-Tropomyosin Exon 6B. J. Biol. Chem. 279: 38249-38259 [Abstract] [Full Text]  
  • Ropers, D., Ayadi, L., Gattoni, R., Jacquenet, S., Damier, L., Branlant, C., Stevenin, J. (2004). Differential Effects of the SR Proteins 9G8, SC35, ASF/SF2, and SRp40 on the Utilization of the A1 to A5 Splicing Sites of HIV-1 RNA. J. Biol. Chem. 279: 29963-29973 [Abstract] [Full Text]  
  • MCLAREN, M., ASAI, K., COCHRANE, A. (2004). A novel function for Sam68: Enhancement of HIV-1 RNA 3' end processing. RNA 10: 1119-1129 [Abstract] [Full Text]  
  • Kress, T. L., Yoon, Y. J., Mowry, K. L. (2004). Nuclear RNP complex assembly initiates cytoplasmic RNA localization. JCB 165: 203-211 [Abstract] [Full Text]  
  • Zahler, A. M., Damgaard, C. K., Kjems, J., Caputi, M. (2004). SC35 and Heterogeneous Nuclear Ribonucleoprotein A/B Proteins Bind to a Juxtaposed Exonic Splicing Enhancer/Exonic Splicing Silencer Element to Regulate HIV-1 tat Exon 2 Splicing. J. Biol. Chem. 279: 10077-10084 [Abstract] [Full Text]  
  • Villemaire, J., Dion, I., Elela, S. A., Chabot, B. (2003). Reprogramming Alternative Pre-messenger RNA Splicing through the Use of Protein-binding Antisense Oligonucleotides. J. Biol. Chem. 278: 50031-50039 [Abstract] [Full Text]  
  • Domsic, J. K., Wang, Y., Mayeda, A., Krainer, A. R., Stoltzfus, C. M. (2003). Human Immunodeficiency Virus Type 1 hnRNP A/B-Dependent Exonic Splicing Silencer ESSV Antagonizes Binding of U2AF65 to Viral Polypyrimidine Tracts. Mol. Cell. Biol. 23: 8762-8772 [Abstract] [Full Text]  
  • Sonza, S., Mutimer, H. P., O'Brien, K., Ellery, P., Howard, J. L., Axelrod, J. H., Deacon, N. J., Crowe, S. M., Purcell, D. F. J. (2002). Selectively Reduced tat mRNA Heralds the Decline in Productive Human Immunodeficiency Virus Type 1 Infection in Monocyte-Derived Macrophages. J. Virol. 76: 12611-12621 [Abstract] [Full Text]  
  • Hutchison, S., LeBel, C., Blanchette, M., Chabot, B. (2002). Distinct Sets of Adjacent Heterogeneous Nuclear Ribonucleoprotein (hnRNP) A1/A2 Binding Sites Control 5' Splice Site Selection in the hnRNP A1 mRNA Precursor. J. Biol. Chem. 277: 29745-29752 [Abstract] [Full Text]  
  • Expert-Bezancon, A., Le Caer, J. P., Marie, J. (2002). Heterogeneous Nuclear Ribonucleoprotein (hnRNP) K Is a Component of an Intronic Splicing Enhancer Complex That Activates the Splicing of the Alternative Exon 6A from Chicken beta -Tropomyosin Pre-mRNA. J. Biol. Chem. 277: 16614-16623 [Abstract] [Full Text]  
  • Vitali, J., Ding, J., Jiang, J., Zhang, Y., Krainer, A. R., Xu, R.-M. (2002). Correlated alternative side chain conformations in the RNA-recognition motif of heterogeneous nuclear ribonucleoprotein A1. Nucleic Acids Res 30: 1531-1538 [Abstract] [Full Text]  
  • Jacquenet, S., Mereau, A., Bilodeau, P. S., Damier, L., Stoltzfus, C. M., Branlant, C. (2001). A Second Exon Splicing Silencer within Human Immunodeficiency Virus Type 1 tat Exon 2 Represses Splicing of Tat mRNA and Binds Protein hnRNP H. J. Biol. Chem. 276: 40464-40475 [Abstract] [Full Text]